Review began 05/15/2022 review ended 05/21/2022 published 05/23/2022 © copyright

HIGHLIGHTS

• who: Report and colleagues from the Pathology, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, GRC , have published the Article: Review began 05/15/2022 Review ended 05/21/2022 Published 05/23/2022 u00a9 Copyright, in the Journal: (JOURNAL) of May/23,/2022
• what: The authors report a DOG1 immunopositivity mesenteric LMS case, the first-ever reported to the best knowledge.

SUMMARY

Leiomyosarcoma (LMS) is a malignant mesenchymal tumor originating from smooth muscle cells or from their precursor mesenchymal stem_cells. Mesenteric LMS is a rare entity with a . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.